NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

多汗症治療的全球市場:產業分析,市場趨勢·規模·預測 (2026年)

Hyperhidrosis Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

出版商 Infinium Global Research (IGR) 商品編碼 1012448
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
多汗症治療的全球市場:產業分析,市場趨勢·規模·預測 (2026年) Hyperhidrosis Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026
出版日期: 2021年05月01日內容資訊: 英文 100 Pages
簡介

全球多汗症治療的市場規模在預測期間 (2020年∼2026年) 內預計將以 5.00%的年複合成長率成長。

本報告提供全球多汗症治療的市場相關分析,提供市場基本結構和主要的影響要素,價值鏈結構,整體市場規模趨勢預測 (2018年∼2026年),各原料·各類型·各功能·各用途及地區別詳細趨勢,主要企業的概要 (簡介·收益趨勢·SWOT分析·最新形勢),今後主要的成長機會·領域等資訊,為您概述為以下內容。

目錄

第1章 序文

第2章 摘要整理

第3章 全球多汗症治療市場:概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 新型冠狀病毒感染疾病 (COVID-19):對多汗症治療市場的影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • IGR-成長矩陣分析:各治療類型
    • IGR-成長矩陣分析:各疾病類型
    • IGR-成長矩陣分析:各終端用戶
    • IGR-成長矩陣分析:各地區
  • 多汗症治療市場價值鏈分析

第4章 多汗症治療市場宏觀指標分析

第5章 全球多汗症治療市場:各治療類型

  • 肉毒桿菌A
  • 雷射治療
  • 外科的治療
  • 局部治療
  • 其他

第6章 全球多汗症治療市場:各疾病類型

  • 原發性局部過汗症
  • 次發性全身性多汗症

第7章 全球多汗症治療市場:各終端用戶

  • 醫院
  • 門診病人手術中心
  • 其他

第8章 全球多汗症治療市場:各地區 (2020年∼2026年)

  • 北美
    • 各治療類型
    • 各疾病類型
    • 各終端用戶
    • 各國
  • 歐洲
  • 亞太地區
  • 其他的國家 (RoW)

第9章 企業簡介和競爭情形

  • 全球多汗症治療市場上競爭情形
  • 企業概要
    • Brickell Biotech, Inc.
    • Sientra, Inc.
    • Revance Therapeutics, Inc.
    • AbbVie, Inc.
    • Allergan, Inc.
    • Brickell Biotech, Inc.
    • Dermira, Inc
    • GlaxoSmithKline plc
    • Ulthera, Inc.
    • TheraVida, Inc.
目錄
Product Code: HC0107

The report on the global hyperhidrosis treatment market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global hyperhidrosis treatment market to grow with a CAGR of 5.00% over the forecast period from 2020-2026. The study on hyperhidrosis treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on hyperhidrosis treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hyperhidrosis treatment market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hyperhidrosis treatment market over the period of 2018 to 2026. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Prevalence of hyperhidrosis
  • Increasing awareness regarding treatment methods

2) Restraints

  • High cost of treatment

3) Opportunities

  • Emergence of new treatments and medications

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global hyperhidrosis treatment market is segmented on the basis of treatment type, disease type, and end-user.

The Global Hyperhidrosis Treatment Market by Treatment Type

  • Botulinum Toxin A
  • Laser Treatments
  • Surgical Treatments
  • Topical Treatments
  • Others

The Global Hyperhidrosis Treatment Market by Disease Type

  • Primary Focal Hyperhidrosis
  • Secondary Generalized Hyperhidrosis

The Global Hyperhidrosis Treatment Market by End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Company Profiles

The companies covered in the report include

  • Brickell Biotech, Inc.
  • Sientra, Inc.
  • Revance Therapeutics, Inc.
  • AbbVie, Inc.
  • Allergan, Inc.
  • Brickell Biotech, Inc.
  • Dermira, Inc
  • GlaxoSmithKline plc
  • Ulthera, Inc.
  • TheraVida, Inc.

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the hyperhidrosis treatment market.

2. Complete coverage of all the segments in the hyperhidrosis treatment market to analyze the trends, developments in the global market and forecast of market size up to 2026.

3. Comprehensive analysis of the companies operating in the global hyperhidrosis treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Hyperhidrosis Treatment Market Highlights
  • 2.2. Hyperhidrosis Treatment Market Projection
  • 2.3. Hyperhidrosis Treatment Market Regional Highlights

3. Global Hyperhidrosis Treatment Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Hyperhidrosis Treatment Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Treatment Type
    • 3.5.2. IGR-Growth Matrix Analysis by Disease Type
    • 3.5.3. IGR-Growth Matrix Analysis by End-user
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Hyperhidrosis Treatment Market

4. Hyperhidrosis Treatment Market Macro Indicator Analysis

5. Global Hyperhidrosis Treatment Market by Treatment Type

  • 5.1. Botulinum Toxin A
  • 5.2. Laser Treatments
  • 5.3. Surgical Treatments
  • 5.4. Topical Treatments
  • 5.5. Others

6. Global Hyperhidrosis Treatment Market by Disease Type

  • 6.1. Primary Focal Hyperhidrosis
  • 6.2. Secondary Generalized Hyperhidrosis

7. Global Hyperhidrosis Treatment Market by End-user

  • 7.1. Hospitals
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Others

8. Global Hyperhidrosis Treatment Market by Region 2020-2026

  • 8.1. North America
    • 8.1.1. North America Hyperhidrosis Treatment Market by Treatment Type
    • 8.1.2. North America Hyperhidrosis Treatment Market by Disease Type
    • 8.1.3. North America Hyperhidrosis Treatment Market by End-user
    • 8.1.4. North America Hyperhidrosis Treatment Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Hyperhidrosis Treatment Market by Treatment Type
    • 8.2.2. Europe Hyperhidrosis Treatment Market by Disease Type
    • 8.2.3. Europe Hyperhidrosis Treatment Market by End-user
    • 8.2.4. Europe Hyperhidrosis Treatment Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Hyperhidrosis Treatment Market by Treatment Type
    • 8.3.2. Asia-Pacific Hyperhidrosis Treatment Market by Disease Type
    • 8.3.3. Asia-Pacific Hyperhidrosis Treatment Market by End-user
    • 8.3.4. Asia-Pacific Hyperhidrosis Treatment Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Hyperhidrosis Treatment Market by Treatment Type
    • 8.4.2. RoW Hyperhidrosis Treatment Market by Disease Type
    • 8.4.3. RoW Hyperhidrosis Treatment Market by End-user
    • 8.4.4. RoW Hyperhidrosis Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Hyperhidrosis Treatment Market
  • 9.2. Companies Profiles
    • 9.2.1. Brickell Biotech, Inc.
    • 9.2.2. Sientra, Inc.
    • 9.2.3. Revance Therapeutics, Inc.
    • 9.2.4. AbbVie, Inc.
    • 9.2.5. Allergan, Inc.
    • 9.2.6. Brickell Biotech, Inc.
    • 9.2.7. Dermira, Inc
    • 9.2.8. GlaxoSmithKline plc
    • 9.2.9. Ulthera, Inc.
    • 9.2.10. TheraVida, Inc.